Scott A. Gangloff Akero Therapeutics, Inc. (AKRO) insider trading activity

AKRO Quotes by TradingView

Scott A. Gangloff is Chief Technology Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AKRO, which is worth approximately $0. The most recent transaction as insider was on Dec 09, 2025, when has been sold 26,351 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Scott A. Gangloff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2025
SELL
Sale (or disposition) back to the issuer
-
26,351 Reduced 100.0%
0 Common Stock
Aug 15 2025
BUY
Exercise of conversion of derivative security
$51,012 $19.62 p/Share
2,600 Added 8.98%
26,351 Common Stock
Jun 30 2025
BUY
Grant, award, or other acquisition
$7,137 $23.87 p/Share
299 Added 1.24%
23,751 Common Stock
Jun 18 2025
SELL
Open market or private sale
$46,504 $54.84 p/Share
848 Reduced 3.49%
23,452 Common Stock
Dec 16 2024
BUY
Grant, award, or other acquisition
-
24,300 Added 50.0%
24,300 Common Stock
SAG

Scott A. Gangloff

Chief Technology Officer
South San Francisco, CA

Track Institutional and Insider Activities on AKRO

Follow Akero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKRO shares.

Notify only if

Insider Trading

Get notified when an Akero Therapeutics, Inc. insider buys or sells AKRO shares.

Notify only if

News

Receive news related to Akero Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKRO